OSCTR-OUHSC PROFILES RESEARCH NETWORKING SOFTWARE IS NOW FUNCTIONAL
The OCTSI has partnered with the OUHSC Department of Pediatrics and been awarded a grant from the National Institutes of Health to develop the Oklahoma Pediatric Clinical Trial Network. This network will be part of the IDeA States Pediatric Clinical Trials Network that is participating in the Environmental Impacts of Child Health Outcomes (ECHO) Program to effectively investigate the impacts of environmental exposures from the womb through later years in a child’s life. The Principal Investigator of this award is Dr. Paul Darden, Chief of General and Community Pediatrics at OUHSC.
Heart disease remains the number one cause of death in the United States, claiming more lives than all cancers combined. Heart disease is also taking a toll on Oklahoma. But the evidence is clear—we can reduce the threat by applying the ABCS of cardiovascular disease prevention: Aspirin use by high-risk individuals, Blood pressure control, Cholesterol management, and Smoking cessation.
OCAST Oklahoma Innovations will air this Saturday and Sunday on the stations below. It will be available on the OCAST website www.ok.gov/ocast/News_Media/Radio_Show , along with a transcript, on Monday.
Researchers with the University of Oklahoma in Tulsa and Oklahoma City have received a $15 million grant to improve heart health in residents throughout the state.
Nobel Laureate to speak at OSCTR Grand Rounds event
Dr. Peter Agre, 2003 Nobel Laureate in Chemistry, will present on "Opening Doors Worldwide through Medical Science" at 12 PM, May 1, 2015 at the Samis Center.
The OSCTR has released the request for proposals for the 2015-2016 OSCTR Pilot Grants. These grants will begin on July 01, 2015. A competitive letter of intent is due February 16, 2015 and the pilot grant application is due March 27, 2015.
We would like all clinical investigators within our Oklahoma Shared Clinical and Translational Resources partner institutions to be aware that the OSCTR Clinical Research space in the Harold Hamm Diabetes Center is now open and available for your clinical research studies.